跳至主要内容
临床试验/IRCT138812222602N3
IRCT138812222602N3已完成3 期

Effect of dark chocolate consumption on ApoB, ApoA-1, lipid profile, hsCRP, glycemic control and blood pressure in type 2 Diabetec patients with hypertention.

Iran University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
35 years 至 65 years(—)
性别
All

入选标准

  • Being volunteer or wishing to attend, 35-65 y old, diagnosed with type 2 diabetes for at least 1 year (FPG = 126 mg/dl or 2hPG = 200 mg/dl), BMI = 40 kg/m2, HbA1C < 9%, Blood pressure = 130/80 mmHg and no regular use of any drugs or supplements with antioxidative (ß-carotene, vitamins C or E) or lipid-lowering properties. Exclusion criteria: Allergy to chocolate, Taking insulin, Smoking cigarette, drinking alcohol or drug abuse, congestive heart failure, malignancies, chronic kidney , hepatic and thyroid diseases , severe cardiac arrhythmias, inflammation following vegetarian or weight-reducing diet 2 months before the study ,Changing medication dosage or physical activity level 2 mo before or during the study.

排除标准

  • 未提供

研究者

相似试验